990 related items for PubMed ID: 9205740
1. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[Abstract] [Full Text] [Related]
2. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Romero A, Gómez F, Villamayor F, Ballesta A, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
[Abstract] [Full Text] [Related]
3. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D, Romero A, Villamayor F, Conejo L, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[Abstract] [Full Text] [Related]
4. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
Maczka M, Kwiecień N, Obtułowicz W, Konturek SJ, Kamiński K, Oleksy J, Gabryelewicz A, Torres J.
J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
[Abstract] [Full Text] [Related]
5. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC, Brzozowski T, Konturek SI, Márquez M, Torres J, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[Abstract] [Full Text] [Related]
6. Study on the increment of the amount of gastric mucus in rats after repeated-dose administration of ebrotidine.
Romero A, Villamayor F, Palop D, Falcó J, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):455-8. PubMed ID: 9205743
[Abstract] [Full Text] [Related]
7. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J, Sánchez JC, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[Abstract] [Full Text] [Related]
8. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I, Puscas C, Coltau M, Torres J, Márquez M, Herrero E, Fillat O, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[Abstract] [Full Text] [Related]
9. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y, Omata T, Abe T, Yoshida A, Ueki S, Aita H, Morita H, Chaki K, Segawa Y, Kurimoto T.
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[Abstract] [Full Text] [Related]
10. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
Decktor DL, Pendleton RG, Kellner AT, Davis MA.
J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
[Abstract] [Full Text] [Related]
11. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL, Piotrowski J, Slomiany A.
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[Abstract] [Full Text] [Related]
12. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H, Ito H, Higaki M, Higaki M, Matsumoto Y, Kamimura T, Katsura Y, Tomishi T, Inoue Y, Takasugi H, Tomoi M, Krakowka S, Yoshida K.
Eur J Pharmacol; 1999 Aug 13; 378(3):299-310. PubMed ID: 10493106
[Abstract] [Full Text] [Related]
13. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
Tarutani M, Sakuma H, Shiratsuchi K, Mieda M.
Arzneimittelforschung; 1985 Aug 13; 35(4):703-6. PubMed ID: 2861823
[Abstract] [Full Text] [Related]
14. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
Anglada L, Raga M, Márquez M, Sacristán A, Castelló JM, Ortiz JA.
Arzneimittelforschung; 1997 Apr 13; 47(4A):431-4. PubMed ID: 9205738
[Abstract] [Full Text] [Related]
15. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K, Kato S, Yamamoto H, Okabe S.
Arzneimittelforschung; 1996 Feb 13; 46(2):177-84. PubMed ID: 8720310
[Abstract] [Full Text] [Related]
16. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I, Puscas C, Coltau M, Pasca R, Torres J, Márquez M, Herrero E, Fillat O, Ortiz JA.
Arzneimittelforschung; 1997 Apr 13; 47(4A):568-72. PubMed ID: 9205767
[Abstract] [Full Text] [Related]
17. Subacute toxicity of ebrotidine in rats and dogs.
Romero A, Grau MT, Villamayor F, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr 13; 47(4A):492-7. PubMed ID: 9205751
[Abstract] [Full Text] [Related]
18. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL, Usakewicz JJ, Buyniski JP.
J Pharmacol Exp Ther; 1983 Jan 13; 224(1):171-9. PubMed ID: 6129316
[Abstract] [Full Text] [Related]
19. Pharmacokinetics of ebrotidine in rats and dogs.
Albet C, Pérez JA, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr 13; 47(4A):483-5. PubMed ID: 9205748
[Abstract] [Full Text] [Related]
20. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.
Frías J, Esteban C, Carcas AJ, Sánchez-García P, Albet C, Torres J, Márquez M, Ortiz JA.
Arzneimittelforschung; 1997 Apr 13; 47(4A):531-4. PubMed ID: 9205759
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
